论文信息 - Cost Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory Pediatric B-Cell Acute Lymphoblastic Leukemia. - 字舞流文

Cost Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory Pediatric B-Cell Acute Lymphoblastic Leukemia.

K. Davis | D. Owens | Benjamin J. Lerman | J. Goldhaber-Fiebert | Y. Tan | Brian C. Boursiquot | John K Lin | James I Barnes | Alex Q L Robinson | B. Lerman | Brian C Boursiquot